Table 2 Mean change of advanced CMR parameters during study period
Mean change in CMR parameter at follow-up CMR | ||||
|---|---|---|---|---|
Total | Alfa | Etl | p-value for treatment effect * | |
N = 48 | N = 23 | N = 25 | ||
LVEF | 0.2 (7.8) | − 0.4 (9.5) | 0.8 (6.0) | 0.513 |
LV CI | 0.19 (0.82) | 0.27 (0.98) | 0.11 (0.65) | 0.998 |
LV GLS | 1.4 (4.3) | 2.6 (4.6) | 0.3 (3.8) | 0.045 |
LV GCS | 0.6 (8.1) | 0.4 (9.1) | 0.8 (7.3) | 0.367 |
LV GRS | − 0.4 (5.7) | − 0.1 (5.7) | − 0.8 (5.7) | 0.381 |
RV GLS | 1.0 (6.1) | 0.8 (6.4) | 1.1 (5.9) | 0.982 |
LA EF | − 2.4 (9.7) | − 1.6 (8.6) | − 3.0 (10.6) | 0.684 |
LA GLS | − 4.2 (9.4) | − 4.5 (10.9) | − 4.0 (7.9) | 0.390 |
T1 time (ms) | 12 (46) | 15 (42) | 10 (50) | 0.411 |
T2 time (ms) | − 0.42 (2.43) | − 0.13(2.45) | − 0.70 (2.43) | 0.652 |